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Conclusion: In patients with severe mitral stenosis and few or no symp-
toms, PMC: 1) Can be safely performed 2) Provides good immediate and
long-term results in a large variety of patients. 3) Should be considered in par-
ticular in patients aged ≤50 years, in whom it prevents functional deterioration
in half of the cases 20 years after PMC.
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Introduction: Percutaneous mitral commissurotomy (PMC) is the alterna-
tive treatment of choice for mitral stenosis (MS). Its immediate and medium
term results are comparable to those of surgical commissurotomy, however in
the long term there is a risk of restenosis. The purpose of this study is to deter-
mine the factors predicting restenosis after PMC.
Methods: 322 patients (66% women), average age: 35 ±13 years (9-75 years)
having a tight MS and treated by PMC with Inoué balloon. The anatomic
aspect of the mitral apparatus before PMC has been studied according to the
criteria of the Wilkins score with a concomitant study of the state of mitral
commissures. The primary success of PMC is defined as follows: mitral area
(MA) post-PMC >1,5 cm2 and gain in MA >25% and mitral regurgitation
(MR) ≤ grade 2. Mitral restenosis is defined as a MA <1,5 cm2 and/or loss
>50% of initial gain in MA.
Results: The rate of primary success of PMC was 86% and mean MA post
PMC was 1,82±0,33 cm² compared to MA pre-PMC of 1±0,18 cm² (p <0.0001).
Opening of two commissures has been observed in 74% of patients. After an
average period of 62±32 months, only 12% of patients had a dyspnea stage III-
IV of NYHA, MA was 1,64±0.3 cm² (p<0.001) and mitral restenosis happened
in 47 patients (20%) after a period of 60,48±27 months (22 – 124 months).
The independent predictors of mitral restenosis after a successful PMC
were: previous surgical commisurotomy, Wilkins score >8, MA after PMC
<1,8 cm² and absence of bicommissural opening post PMC.
Conclusion: A favorable anatomy of mitral apparatus and the optimisation
of immediate result of PMC are the guaranty for the maintain of good result
in the long term.
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Methods: We performed percutaneous mitral balloon commisurotomy
(PMC) in 361 patients to compare the effectiveness of PMC between patients
with mitral restenosis after surgical commissurotomy (group 1) and patients
with unoperated mitral stenosis (group 2). Thirty-nine had undergone closed
or open mitral commissurotomy 8.4 years before.
Results: There were no significant differences in clinical profiles between
the two groups. The mitral valve area was increased from 1.1 0.31 to 1.94
0.58 cm2 in group 1 and 0.94 0.3 to 2 0.7 cm2 in group 2 (p>0.05). The mitral
gradient was decreased from 14.6 5.9 to 6 2.6 mm hg in group 1 and 18 7.0
to 7 5.3 mm hg in group 2 (p>0.05). The increment of mitral regurgitation and
significant left to right shunt after PMC were not significantly different (8.9%
versus 13.7%, 4.2% versus 8.4% respectively). Optimal results were attained
in 81% of the patients in group 1 and in 88.3% of the patients in group 2
(p>0.05).
Conclusion: These results suggest PMC in mitral restenosis after surgical
commissurotomy may be safe in selected patients and may be equally effec-
tive as in unoperated mitral stenosis.
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Background: Previous studies have reported inconsistencies between
echocardiographic parameters of severity in aortic valve stenosis (AS). Peak
aortic valve velocity (Vmax) strongly predicts outcome in AS patients. The
present study was therefore designed to identify the cut-off values of echocar-
diographic parameters of severity in normal flow (NF) AS corresponding to a
Vmax ≥3 m/s, ≥4 m/s, 5 m/s or 5.50 m/s. This study was therefore designed to
identify the cut-off values of echocardiographic parameters of severity that
correspond to Vmax≥3, 4, 5 and 5.5 m/s.
Methods and results: We retrospectively reviewed the echocardiograms
of 528 consecutive patients with AS, left ventricular (LV) ejection frac-
tion>0.50 and NF (stroke volume index>35 mL/m²). The accuracy of mean
pressure gradient (MPG), aortic valve area (AVA), and indexed AVA for BSA
(IAVA) to predict Vmax≥3, 4, 5 and 5.5 m/s ranged from 0.89 to 0.99, and
the best predictor was MPG for various levels of Vmax. The best values of
MPG, AVA, and IAVA to predict Vmax≥3 m/s were 22 mmHg, 1.15 cm2,
0.60 cm2/m2, respectively. While a cut-off of Vmax≥4 m/s to define severe AS
was consistent with a value of 39 mmHg for MPG, corresponding values for
AVA and IAVA of 0.90 cm² and 0.48 cm²/m² respectively were substantially
different from those recommended in current guidelines. MPG≥60 and
65mmHg, AVA≤0.76 and ≤0.68 cm², and IAVA≤0.41 and ≤0.35 cm2/m2 were
identified as predictors of Vmax≥5 m/s and ≥5.5 m/s (very severe AS), respec-
tively.
Conclusions: Guidelines recommended cut-off values for AVA and IAVA
are not consistent with those of Vmax and MPG. The results of the present
study may serve as safeguards in case of apparent inconsistencies between
echocardiographic parameters of severity in NF AS.
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Background: The exact prevalence, characteristics and impact on both
short- and long-term outcome of low flow, low gradient severe aortic stenosis
(LFLG) despite preserved left ventricular ejection fraction (LVEF), remain
debatable. The aim of our study is to describe the outcome of a large group of
patients with LFLG AS using cardiac catheterization data.
Methods and Results: Between 2000 and 2010, 770 patients with pre-
served LVEF (>50%) and severe AS (valve area <1cm²) without significant
other valvular heart disease having underwent cardiac catheterization, were
retrospectively analyzed. Mean age was 74±8 years, 42% were female, 46%
had associated coronary artery disease. LFLG (indexed LV stroke
volume<35 mL/m² and mean pressure gradient<40 mm Hg) were found in
13% of patients (n=99), normal flow/high gradient (NFHG) in 50% (n=388),
LFHG in 14% and NFLG in 22%.
In comparison with classical patients with NFHG, those with LFLG were
significantly older, and more often female. The cardiac cathererization hemo-
dynamic data including the systemic compliance, vascular systemic resis-
tances and the valvulo-arterial impedance were significantly impaired in
LFLG patients as compared to those with NF/HG. Thirty-days mortality was
higher in patients with LFLG when compared to NFHG (9 vs. 4%, p=0.06)
and 10-year survival was significantly reduced in LFLG (32±8%) when com-
pared to NFHG (66±4%; p=0.0005) (figure). Furthermore, after adjustment for
